Thermo Fisher Scientific Inc
NYSE:TMO
Thermo Fisher Scientific Inc
Operating Income
Thermo Fisher Scientific Inc
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Operating Income
$7.3B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
14%
|
CAGR 10-Years
15%
|
|
Danaher Corp
NYSE:DHR
|
Operating Income
$9.5B
|
CAGR 3-Years
20%
|
CAGR 5-Years
26%
|
CAGR 10-Years
12%
|
|
West Pharmaceutical Services Inc
NYSE:WST
|
Operating Income
$705.1m
|
CAGR 3-Years
19%
|
CAGR 5-Years
23%
|
CAGR 10-Years
16%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Operating Income
$1.1B
|
CAGR 3-Years
11%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
Agilent Technologies Inc
NYSE:A
|
Operating Income
$1.3B
|
CAGR 3-Years
11%
|
CAGR 5-Years
6%
|
CAGR 10-Years
16%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Operating Income
$2.1B
|
CAGR 3-Years
38%
|
CAGR 5-Years
21%
|
CAGR 10-Years
16%
|
See Also
What is Thermo Fisher Scientific Inc's Operating Income?
Operating Income
7.3B
USD
Based on the financial report for Dec 31, 2023, Thermo Fisher Scientific Inc's Operating Income amounts to 7.3B USD.
What is Thermo Fisher Scientific Inc's Operating Income growth rate?
Operating Income CAGR 10Y
15%
Over the last year, the Operating Income growth was -14%. The average annual Operating Income growth rates for Thermo Fisher Scientific Inc have been -2% over the past three years , 14% over the past five years , and 15% over the past ten years .